IFI6 and esophageal squamous cell carcinoma: Intriguingly, IFI6-KD ESCC cells treated with MitoTEMPO (20 μM), a mitochondria-specific antioxidant, exhibited only a partial reversal of IFI6 silencing-induced cellular ROS generation compared with vector-treated ESCC cells (Fig. 8a, b).